Clinical trial
Protocol to Examine Methylation of Tumor Suppression Genes in Women at High Risk…
NCT00323908 · Carol Fabian, MD, Other · Completed
Key facts
| NCT number | NCT00323908 |
|---|---|
| Title | Protocol to Examine Methylation of Tumor Suppression Genes in Women at High Risk of Developing Breast Cancer |
| Official title | QM-MSP, Ki-67, and Cytomorphology of RPFNA Specimens From High Risk Women |
| Lead sponsor | Carol Fabian, MD, Other |
| Collaborators | University of Alabama at Birmingham Avon Foundation National Cancer Institute (NCI) NIH Johns Hopkins University |
| Status | Completed |
| Study type | Observational |
| Conditions | Breast Cancer |
| Enrollment | 281 |
| Start date | Jun 1, 2005 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | May 10, 2006 |
| Last update posted | May 22, 2023 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: